NEW YORK (GenomeWeb News) – InforSense secured $10 million during its latest investment round, the analytics company said today.
 
Fleming Family & Partners Private Equity and Imperial Innovations Group led the round. Other participating investors included Elaia Partners and Sitka Health Fund VCT.
 

InforSense plans to use the funds to expand globally, develop new products, and launch application initiatives in its current and new markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.